John Jairo Perez

Address:

38 Camden Ln, Boynton Beach, FL 33426

VIN:

1B3HB28B27D576790

Make:

DODGE

Model:

CALIBER

Year:

2007

US Patent:

20140013965, Jan 16, 2014

Filed:

Sep 28, 2013

Appl. No.:

14/040621

Inventors:

John Perez - Plantation FL, US

International Classification:

A47J 39/00

US Classification:

99483

Abstract:

The food warmer apparatus is disclosed. The food warmer includes a water pan for holding water, a housing for supporting the water pan, a food pan supported by the water pan above the water, and an electrical heating element located underneath, and in conductive contact with, the water pan, so as to heat the water in the water pan. The food warmer also includes a first and second removable battery for providing power to the electrical heating element, and a processor conductively coupled with the electrical heating element and with the first and second removable batteries, wherein the processor is configured for engaging a switch for relaying power to the electrical heating element from the first battery, detecting that the first battery has depleted below a threshold, and engaging a switch for relaying power to the electrical heating element from the second battery.

US Patent:

20210085773, Mar 25, 2021

Filed:

Dec 8, 2020

Appl. No.:

17/114802

Inventors:

- New York NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Rasappa Gounder Arumugham - Lansdale PA, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - New City NY, US
Lakshmi Khandke - Nanuet NY, US
Bounthon Loun - North Reading MA, US
John Lance Perez - Doylestown PA, US
Gary Warren Zlotnick - San Antonio TX, US

Assignee:

Pfizer Inc. - New York NY

International Classification:

A61K 39/095
A61K 39/00
C07K 14/22
A61K 39/295
A61K 47/64
A61K 39/12
A61K 47/02
A61K 47/22
A61K 47/26

Abstract:

In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 μg/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 μg/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.

US Patent:

20200405838, Dec 31, 2020

Filed:

Sep 17, 2020

Appl. No.:

17/024618

Inventors:

- NEW YORK NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Judith Absalon - New York NY, US
Johannes Frederik Beeslaar - Farnham, GB
David Cooper - Monroe NY, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - Bluffton SC, US
Isis Kanevsky - New York NY, US
Lakshmi Khandke - Nanuet NY, US
Paul Liberator - Holmdel NJ, US
John Lance Perez - Doylestown PA, US
Lynn Marie Phelan - Lake Hiawatha NJ, US
Gary Warren Zlotnick - San Antonio TX, US

Assignee:

PFIZER INC. - NEW YORK NY

International Classification:

A61K 39/095
C07K 14/22
C07K 16/12
A61K 47/18
A61K 47/10
A61K 47/26
A61K 31/7028
A61K 47/64
A61P 31/00
A61K 39/12

Abstract:

In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.

US Patent:

20200164056, May 28, 2020

Filed:

Dec 5, 2019

Appl. No.:

16/704701

Inventors:

- NEW YORK NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Judith Absalon - New York NY, US
Johannes Frederik Beeslaar - Farnham, GB
David Cooper - Monroe NY, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - Bluffton SC, US
Isis Kanevsky - New York NY, US
Lakshmi Khandke - Nanuet NY, US
Paul Liberator - Holmdel NJ, US
John Lance Perez - Doylestown PA, US
Lynn Marie Phelan - Lake Hiawatha NJ, US
Gary Warren Zlotnick - San Antonio TX, US

Assignee:

PFIZER INC. - NEW YORK NY

International Classification:

A61K 39/095
A61P 31/00
A61K 47/64
A61K 31/7028
A61K 47/26
A61K 47/10
A61K 47/18
C07K 16/12
C07K 14/22
A61K 39/12

Abstract:

In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.

US Patent:

20190231861, Aug 1, 2019

Filed:

Nov 20, 2018

Appl. No.:

16/196150

Inventors:

- NEW YORK NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Judith Absalon - New York NY, US
Johannes Frederik Beeslaar - Farnham, GB
David Cooper - Monroe NY, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - New City NY, US
Isis Kanevsky - New York NY, US
Lakshmi Khandke - Nanuet NY, US
Paul Liberator - Holmdel NJ, US
John Lance Perez - Doylestown PA, US
Lynn Marie Phelan - Lake Hiawatha NJ, US
Gary Warren Zlotnick - San Antonio TX, US

Assignee:

PFIZER INC. - NEW YORK NY

International Classification:

A61K 39/095
A61K 31/7028
C07K 14/22
A61K 47/26
A61K 47/64
A61K 47/18
C07K 16/12
A61P 31/00
A61K 47/10

Abstract:

In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.

US Patent:

20180214532, Aug 2, 2018

Filed:

Jan 30, 2018

Appl. No.:

15/883334

Inventors:

- New York NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Judith Absalon - New York NY, US
Johannes Frederik Beeslaar - Farnham, GB
David Cooper - Monroe NY, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - New City NY, US
Isis Kanevsky - New York NY, US
Lakshmi Khandke - Nanuet NY, US
Paul Liberator - Holmdel NJ, US
John Lance Perez - Doylestown PA, US
Lynn Marie Phelan - Lake Hiawatha NJ, US
Gary Warren Zlotnick - San Antonio TX, US

International Classification:

A61K 39/095
C07K 14/22
C07K 16/12
A61K 31/7028
A61K 47/10
A61K 47/26
A61K 47/18

Abstract:

In one aspect, the invention relates to a composition including a factor H binding protein (fHBP) and a non-serogroup B capsular polysaccharide. The invention further relates to uses of a composition that includes fHBP, such as, for example, uses to elicit an immune response against serogroup B strains and non-serogroup B strains. The compositions and methods described herein are directed to administration in humans, including adults, adolescents, toddlers, and infants.

US Patent:

20180197512, Jul 12, 2018

Filed:

Mar 6, 2018

Appl. No.:

15/913489

Inventors:

John A. PEREZ - Chandler AZ, US

International Classification:

G10H 1/18
G10H 1/043
G10H 1/34

Abstract:

A system and method for interfacing and controlling multiple musical instrument effects modules and pedals on a common platform. The system includes: a system processor; a backplane coupled with the system processor; a plurality of musical instrument effects modules removably inserted into the backplane, a plurality of musical instrument effects pedals removably inserted into the backplane via looper channels, each of the plurality of musical instrument effects modules and pedals including an audio input signal interface and an audio output signal interface, at least one of the musical instrument effects modules including a programmable potentiometer and/or programmable switch to modify an audio output signal; and a user interface configured to enable a user to apply a desired setting on the programmable potentiometer of the musical instrument effects modules via the system processor and the backplane: and a user interface configured to enable a user to reorder the musical effects signal path by dragging and dropping a module or pedal icon to a desired position among a plurality of icons thus electrically reordering the effects signal path.

US Patent:

20180000923, Jan 4, 2018

Filed:

Feb 16, 2016

Appl. No.:

15/543232

Inventors:

- New York NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Rasappa Gounder Arumugham - Lansdale PA, US
John Erwin Farley - Chapel Hill NC, US
Leah Diane Fletcher - Geneseo NY, US
Shannon Lea Harris - Nanuet NY, US
Thomas Richard Jones - New City NY, US
Lakshmi Khandke - Nanuet NY, US
Bounthon Loun - North Reading MA, US
John Lance Perez - Doylestown PA, US
Gary Warren Zlotnick - San Antonio TX, US

International Classification:

A61K 39/095
A61K 39/12
A61K 47/22
A61K 47/64
A61K 47/26
A61K 47/02
A61K 39/00

Abstract:

In one aspect, the invention relates to a composition including a first polypeptide having the sequence set forth in SEQ ID NO: 1 and a second polypeptide having the sequence set forth in SEQ ID NO: 2. In one embodiment, the composition includes about 120 μg/ml of a first polypeptide including the amino acid sequence set forth in SEQ ID NO: 1, 120 μg/ml of a second polypeptide including the amino acid sequence set forth in SEQ ID NO: 2, about 2.8 molar ratio polysorbate-80 to the first polypeptide, about 2.8 molar ratio polysorbate-80 to the second polypeptide, about 0.5 mg/ml aluminum, about 10 mM histidine, and about 150 mM sodium chloride. In one embodiment, a dose of the composition is about 0.5 ml in total volume. In one embodiment, two-doses of the composition induce a bactericidal titer against diverse heterologous subfamily A and subfamily B strains in a human.